Enhanced physical health screening for people with severe mental illness in Hong Kong: results from a one-year prospective case series study by Bressington, D. et al.
Canterbury Christ Church University’s repository of research outputs
http://create.canterbury.ac.uk
Please cite this publication as follows: 
Bressington, D., Mui, J., Hulbert, S., Cheung, E., Bradford, S. and Gray, R. (2014) 
Enhanced physical health screening for people with severe mental illness in Hong 
Kong: results from a one-year prospective case series study. BMC Psychiatry, 14 
(57). 
Link to official URL (if available):
http://dx.doi.org/10.1186/1471-244X-14-57
This version is made available in accordance with publishers’ policies. All material 
made available by CReaTE is protected by intellectual property law, including 
copyright law. Any use made of the contents should comply with the relevant law.
Contact: create.library@canterbury.ac.uk
RESEARCH ARTICLE Open Access
Enhanced physical health screening for people
with severe mental illness in Hong Kong: results
from a one-year prospective case series study
Daniel Bressington1*, Jolene Mui2, Sabina Hulbert3, Eric Cheung4, Stephen Bradford5 and Richard Gray6
Abstract
Background: People with severe mental illness have significantly poorer physical health compared to the general
population; previous health screening studies conducted outside Asian countries have demonstrated the potential
in addressing this issue. This case series aimed to explore the effects and utility of integrating an enhanced physical
health screening programme for community dwelling patients with severe mental illness into routine clinical
practice in Hong Kong.
Method: This study utilises a consecutive prospective case series design. The serious mental illness Health
Improvement Profile (HIP) was used as a screening tool at baseline and repeated at 12 months follow-up.
Results: A total of 148 community-based patients with severe mental illness completed the study. At one year
follow-up analysis showed a significant improvement in self-reported levels of exercise and a reduction in the
numbers of patients prescribed medications for diabetes However, mean waist circumference increased at follow-up. In
addition to the statistically significant results some general trends were observed, including: a lack of deterioration in
most areas of cardiovascular risk; a reduction in medicines prescribed for physical health problems; and general
improvements in health behaviours over the 12 month period.
Conclusions: The findings demonstrate that using the HIP is feasible and acceptable in Hong Kong. The results of
the enhanced physical health-screening programme are promising, but require further testing using a randomised
controlled trial design in order to more confidently attribute the improvements in well-being and health behaviours to
the HIP.
Trial registration: Clinical trial registration number: ISRCTN12582470
Keywords: Physical health screening, Severe mental illness, Health behaviours, Cardiovascular risk
Background
The poor physical health state of people with severe
mental illness (SMI) is well established [1]; people with
SMI are at significantly increased risk from a variety of
long term physical health problems in comparison to the
general population. The increased morbidity of physical
health conditions such as cardiovascular disease, obesity,
diabetes, metabolic syndrome and hypertension have led to
high mortality rates in people with SMI; in schizophrenia,
standardised mortality ratios are increased up to four-fold
compared with the general population [2-5]. It is estimated
that people with SMI have a life-span of between 10 and
30 years less than the general population; which has been
observed to be deteriorating over the last decade [6].
In response to the physical health inequalities observed
in people with SMI many health care providers in a variety
of different countries have produced policies and clinical
guidelines which recommend regular physical health
screening in this patient group [4,7-9]. The increased
focus on the physical health of people with SMI has also
resulted in some countries using financial incentives to
improve the regularity of screening; for example, in the
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UK general medical practitioners in primary care settings
are offered additional payment for recording the health
status of people with SMI [10].
Service improvement and implementation studies have
demonstrated that clinicians in mental health services
are able to successfully conduct enhanced physical health
screening when they are provided with sufficient guidance,
training and resources; for example Mangurian et al., [11]
reported that 50% of 15,000 outpatients in New York State
were able to have Body Mass Index, blood pressure and
smoking status recorded over just a four month period.
Similarly in the UK; Barnes et al., [12] reported that a
quality improvement programme effectively increased
levels of screening for metabolic syndrome in community
psychiatric patients prescribed antipsychotics. An earlier
study conducted in the US [13] reinforces the potential
benefits of screening as the results demonstrated that
structured health monitoring was effective in detecting
physical health problems in people with mental illness.
Once physical health co-morbidities have been identified,
interventions to address the problems need to be tailored
for patients based on their individual circumstances.
Reasons for the poor physical health state of individuals
with SMI are multi-factorial; but are likely to relate to a
combination of lifestyle issues, diagnostic over-shadowing,
adverse effects of prescribed medication, difficulty detecting
physical health concerns, patient reluctance to report health
problems and the potential impact of psychiatric symptoms
on health behaviours [6,14]. A recently published system-
atic review of the physical health intervention literature
[15] concluded that mental health nurses were well-placed
to address health behaviours in mental health patients
and that specific interventions can result in significant
improvements in both health behaviours and physical
health outcomes. Although there is currently a lack of
evidence from randomised controlled trials [16] the results
from less methodologically robust studies suggest that
“well-being” initiatives may result in improved patient
outcomes [17,18].
Given the close relationship between lifestyle and health,
some studies have investigated the use of enhanced
screening procedures which combine the identification
of both physical co-morbidity and the health behaviours
of patients in order to target clinical interventions. With
this intention, White et al., [19] developed the serious
mental illness Health Improvement Profile (HIP) screen-
ing tool and through a pilot study demonstrated the face
validity and acceptability of the HIP to both clinicians and
patients. The HIP is intended to be used by mental health
nurses as a pragmatic physical health risk assessment
which aims to direct individualised clinical interventions
based on the patient’s physical health state and their
responses to the questions about health behaviours.
The HIP consists of 27 items which are flagged as “red”
for unhealthy (indicating that intervention is required) or
“green” for healthy (where no intervention is required).
Subsequently, a pilot study which aimed to establish
the clinical utility of the HIP was conducted by Shuel
et al., [20] in the UK. The tool was completed with 31
community mental health patients and the results showed
that mental health nurses effectively detected physical
comorbidity and were also able to use the findings to
plan and recommend tailored evidence-based interven-
tions. The study’s qualitative data further demonstrated
that using the HIP was acceptable to patients and their
clinicians.
The previous physical health screening studies are
primarily confined to English speaking countries and
as there have been no similar studies to date that have
been carried out in Asian populations the transferability
of the intervention beyond western cultures has yet to be
ascertained. Therefore, this prospective case series aims to
demonstrate proof of concept by exploring the use of a
health improvement screening tool (HIP) [19] in Hong
Kong. The authors of the HIP state that the measure
should be used as a tool for eliciting positive change [19],
and therefore this study also aims to seek to establish
the potential effects of utilising the HIP by repeating the
measure at 12 months follow-up.
Study aims
 To explore the utility and potential impact of the
HIP screening tool in routine clinical practice on the
physical health state and health behaviours of people
with SMI after 12 months.
Methods
Study design
The study utilises a prospective case series study design.
The HIP was used as a screening tool at baseline and
repeated at 12 months follow-up. In addition to gathering
longitudinal data about physical state and health behaviours
over one year, the findings were used to inform potential
individualised interventions. The following demographic
and clinical characteristics were also recorded: age, gender,
education, marital status, diagnosis, duration of illness,
employment status and prescribed medication.
Recruitment and selection
The 30 Community Psychiatric Nurses (CPNs) who par-
ticipated in the study were trained in how to use the HIP
and how to conduct the required physical examinations.
Each CPN aimed to recruit 5 patients who met the inclu-
sion criteria and complete the HIP with them at baseline
and at 12 months follow-up. In line with a consecutive
recruitment strategy; CPNs sought informed consent from
the patients who they were scheduled to see for routine
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appointments until a minimum of at least 5 patients
agreed for their data to be used.
Patients were approached for consent if they met the
following inclusion criteria:
(1)Male or female. Aged from 18–65 years; (2) with a
diagnosis of SMI defined by a case-note diagnosis of
schizophrenia, schizoaffective disorder, psychotic
depression or bipolar affective disorder (type 1 or 2).
Any service user who did not have capacity to provide
informed consent was excluded from the study.
Ethical considerations
Ethical approval was obtained from the Hong Kong New
Territories West Cluster Clinical and Research Ethics
Committee prior to commencement of the project. Partic-
ipants who met the inclusion criteria were required to
provide written informed consent in order to participate;
the participant information sheets reiterated that taking
part was entirely voluntary and those patients who declined
to take part would not have their clinical treatment
negatively influenced.
Data collection
This study used the HIP [19] as a screening tool. The items
and parameters included in the tool were identified using
a systematic review of the literature. The gender specific
tool contains 27 items which are designed to highlight in-
dicators of physical health risk in people with SMI (Table 1
provides details of the 27 items included on the HIP). Data
relating to the psychometric properties of the HIP have
not been established/reported; however the face validity,
patient acceptability and clinical utility have been demon-
strated in a UK population of SMI patients [19,20].
The parameters for use in Hong Kong required modifi-
cation in relation to waist circumference and Body Mass
Index (BMI) to ensure that they reflected the values
recommended for an Asian population. As there has been
some debate in the literature about the most relevant BMI
cut off points for being defined as overweight in Hong
Kong [21], for clarity we present the results of numbers of
patients with a BMI of ≥23 kg/m2 (the usual cut-off value
for being determined as overweight in a Chinese popula-
tion) and ≥25 kg/m2 (the usual cut-off value for being
overweight in a European population).
The biometric data (blood tests etc.) required to complete
the HIP were obtained from the most recent outpatient
records and patients were therefore not required to
undergo any investigations that would not normally be
considered as part of routine clinical practice. CPNs col-
lected data to ensure that they would be immediately
aware of physical health problems that were detected and
also be able to recommend health behaviour interventions
or refer patients to the appropriate existing clinical service
based on the findings from the HIP.
Data analysis strategy
Data were entered into SPSS version 21. Descriptive statis-
tical analysis was undertaken to establish means/standard
deviations and frequencies at baseline and follow-up.
Paired samples T-tests were conducted to explore signifi-
cant differences in the pre and post means of continuous
variables, whilst Chi-square or McNemar tests were
conducted to determine differences in the categorical
variables at baseline and follow-up. Further analysis of
variance and binomial logistic regression were conducted
to explore the origins of observed change in selected
variables.
Results
A total of 222 patients were assessed for eligibility and
were approached for consent to participate in the study;
15 of these declined to take part and therefore a total of
207 HIPs were completed at baseline during February
2012. The follow-up measures were completed during
February and March 2013, for a variety of reasons 59
participants (29%) were lost to follow-up and therefore
data from 148 participants were analysed. The specific
reasons for attrition are detailed in the study flow diagram
(Figure 1).
Demographic and clinical characteristics of study
participants
The demographic and clinical characteristics of participants
are presented in Table 2. All patients involved in this study
were of Chinese ethnicity and residents of the Hong Kong
New Territories. The mean age was 47.14 years (range
21–70; SD 10.61). On average they had been diagnosed
Table 1 HIP items
1. Body mass index 15. Breast check (female and male)
2. Waist circumference 16. Menstrual cycle (female)
3. Pulse 17. Smoking status
4. Blood pressure 18. Exercise
5. Temperature 19. Alcohol intake
6. Liver function tests 20. Diet: 5-a-day
7. Lipid levels 21. Diet: fat intake
8. Glucose 22. Fluid intake
9. Cervical smear (women only) 23. Caffeine intake
10. Prostate and testicles check
(men only)
24. Cannabis use
11. Sleep 25. Safe sex
12. Teeth 26. Urine
13. Eyes 27. Bowels
14. Feet 28. Sex satisfaction
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with a SMI for 13.36 years (range 0.5-43; SD 10.16); the
majority (66%) having a diagnosis of schizophrenia or
related disorders and one quarter of participants being
diagnosed with a mood-related disorder. Two-thirds of
patients were single or divorced, and just under a third
(29%) were married. The majority of patients (65%) were
educated to secondary school level and above, whilst six
had no formal education. Only a quarter of participants
were employed with the remainder being unemployed,
retired or looking after the family home.
Prescribed medications at baseline and follow-up
Prescribed medications at baseline and follow-up are
detailed in Table 3. Prescriptions for psychotropic medica-
tions changed very little between both time points. At
baseline over 85% of patients in this study were pre-
scribed an antipsychotic medication; the mean number
of prescribed antipsychotics was 1.11 (range: 0–3; SD
0.63), the majority of these were atypical antipsychotics
and just over 20% were prescribed two or more antipsy-
chotics. Just under a quarter of patients were receiving their
antipsychotics as long acting intramuscular injections. At
follow-up the mean number of antipsychotic medications
prescribed remained the same as at baseline (mean: 1.11;
SD 0.65) and just over 10% of patients at both baseline
and follow-up were not prescribed any antipsychotics.
The numbers of patients prescribed medications for
physical health problems slightly reduced at follow-up;
however, McNemar tests reveal that the only statistically
significant reduction was in the numbers of people being
prescribed treatment for diabetes (p = 0.04). Very few
patients were receiving medications for hypercholes-
terolemia at both time points, whilst prescriptions for
hypertension reduced at follow-up from 21% to 14% of
patients.
Cardiovascular risk measurements at baseline and follow-up
Table 4 outlines the mean values of cardiovascular risk
measurements at both time points. The mean Body Mass
Index (BMI) at baseline and follow-up was just over 25,
which suggests being overweight as determined by both
European and Asian criteria. Although all the means
(except waist circumference and LDL cholesterol) were
reduced at follow-up, the paired samples T-tests show
that only waist circumference significantly increased at
follow-up (t = −2.165; df = 89; p = 0.03). The sparseness
of data relating to blood tests that were obtained from
outpatients records may account for the lack of statistical
significance due to lack of power.
Flagged indicators of cardiovascular risk at baseline and
follow-up
Table 5 shows the number of patients’ flagged red or
green for a variety of cardiovascular risk indicators. With
the exception of waist circumference and raised fasting
blood glucose levels the numbers of patients being red-
flagged reduced in all other areas at follow-up. Over three
quarters were deemed to be overweight in accordance with
Assessed for eligibility and 
approached for consent (n=222)
Excluded (total) (n=15)
♦ Declined to participate (n=15 )
Analysed  (n=148)
♦ Excluded from analysis (give reasons) (n=0 )
Analysis
Follow-Up(One Year)
Recruited (n=207)
Enrollment
Lost to follow-up (total) (n=59)
• Withdrew consent (n=6 )
• Discharged from service (n=41)
• Untraceable (n= 2)
• Died (n=2; one accidental fall, one liver 
cancer)
• Transferred to other region (n=6) 
• Self-discharged from service (n=2 )
Figure 1 Physical health screening - study flow diagram.
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Asian BMI criterion at baseline and this reduced to just
over 71% at follow-up. Although general improvements
were observed at follow-up none of the differences are
statistically significant at the p < 0.05 level. The deterio-
rations in waist circumference and blood glucose levels
are also not significant, however the McNemar test shows
that the increase in numbers of patients with waist
circumference measurement suggesting central obesity
is approaching significance (p = 0.07).
Patient’s health behaviours
Table 6 outlines the patients’ health behaviours at both
baseline and follow-up. Similarly to the cardiovascular
risk factors results, all health behaviours (except sleep
disruption) had improved at follow-up. However, the
only statistically significant result relates to an improve-
ment in the numbers of patients at follow-up reporting
that they exercise at recommended levels (p = 0.02). The
numbers of patients reporting sleep disruption increased
from 27% to 34% at follow-up, however this is not signifi-
cant at the p < 0.05 level (p = 0.15).
Table 2 Demographic and clinical characteristics of
participants
Demographic Number (%)
Gender
Male 64 (43.2)
Female 84 (56.8)
Marital status
Single 57 (38.5)
Married 44 (29.7)
Widowed 10 (6.8)
Divorced 36 (24.3)
Unknown 1 (0.7)
Educational level
None 6 (4.1)
Primary 45 (30.4)
Secondary 83 (56.1)
University/post graduate 13 (8.8)
Unknown 1 (0.7)
Diagnosis
Schizophrenia 53 (35.8)
Paranoid Schizophrenia 35 (23.6)
Delusional disorder 10 (6.8)
Bipolar affective disorder (BPAD) 15 (10.1)
Psychotic depression 23 (15.5)
Other (i.e. schizoaffective disorder;
non-specified psychosis)
10 (6.8)
Unknown 2 (1.4)
Employment status
Unemployed 68 (45.9)
Employed 39 (26.3)
Homemaker 35 (23.6)
Retired/other 5 (3.4)
Unknown 1 (0.7)
Table 3 Prescribed Medication at baseline and follow-up
Medication variable Baseline -
number (%)
Follow-up -
number (%)
Significance (P)
Number of
antipsychotics
prescribed
P = 0.71
0 19 (12.8) 18 (12.2)
1 95 (64.2) 98 (66.2)
2 30 (20.3) 29 (19.6)
3 4 (2.7) 3 (2.0)
Prescribed first
generation
antipsychotics
P = 0.17
Yes 52 (35.1) 45 (30.4)
No 96 (64.9) 102 (68.9)
Unknown 1 (0.7)
Prescribed
second generation
antipsychotics
P = 0.73
Yes 92 (62.2) 93 (62.8)
No 56 (37.8) 54 (36.5)
Unknown 1 (0.7)
Prescribed clozapine P = 1.00
Yes 13 (8.8) 12 (8.1)
No 135 (91.2) 136 (91.9)
Prescribed long acting
antipsychotic injection
P = 1.00
Yes 34 (23.0) 33 (22.3)
No 114 (77.0) 114 (77.0)
Unknown 1 (0.7)
Prescribed an
antihypertensive
P = 0.07
Yes 32 (21.6) 21 (14.2)
No 116 (78.4) 125 (84.5)
Unknown 2 (1.4)
Prescribed a statin P = 1.00
Yes 6 (4.1) 5 (3.4)
No 142 (95.9) 143 (96.6)
Prescribed diabetes
treatment
P = 0.04*
Yes 16 (10.8) 8 (5.4)
No 132 (89.2) 140 (94.6)
P for significant difference between baseline and follow-up – tested by McNemar
test. *Statistically significant at p < 0.05.
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Secondary analyses
In order to further explore the origins of the significant
change we observed in waist circumference, we conducted
analyses of variance and binomial logistic regression.
In the first instance, we used five classifications of BMI
values that suggest different levels of obesity (under-
weight ≤ 18.49 kg/m2, normal weight = 18.50-24.99 kg/m2,
overweight = 25-29.99 kg/m2, obese = 30-39.99 kg/m2,
morbid obesity ≥ 40 kg/m2) as a between subjects factor to
detect mean differences in waist circumference change
(computed as the difference between measurements at
baseline and follow-up). The ANOVA showed no signifi-
cant difference between the five BMI categories in terms
of waist change F (4,85) = 0.611, p = 0.66. We then then
conducted a binomial logistic regression in order to pre-
dict levels of waist change (where no changes or decreases
in waist circumference measurements between baseline
and follow up were recoded as 0 and increases were
recoded as 1) from a mixture of categorical (gender,
diagnosis, occupation, prescribed medication) and con-
tinuous (age, duration of illness) predictors. None of the
models calculated (simultaneous or stepwise) resulted in a
fitting model able to correctly predict cases much beyond
chance.
Discussion
The physical health state of the patients involved in this
study is markedly worse than the general Hong Kong
population. Although direct comparisons are complicated
by differing settings and age distributions, data reported
by Ko et al., [21] suggests that 44% of women and 68% of
men aged 40–50 years in the Hong Kong working popula-
tion were overweight (defined as a BMI ≥23) and the
current study indicates that at baseline 77% of men and
76% women are overweight. In terms of waist circum-
ference; Ko et al., [22] estimate the prevalence of central
obesity as 30% for men and 29% for women, whilst our
study shows that 42% of women and 61% of men were cen-
trally obese at baseline. Therefore, these results indicate
that men are more than twice as likely to have central
obesity and women are over 1½ times more likely to be
overweight compared to the general population; findings
which are supported by a number of other studies con-
ducted in different countries that estimate the relative risk
of obesity in people with schizophrenia as being between
1.5 and 2 [6,23,24].
This study shows that the challenges mental health
practitioners face when promoting physical health in
Hong Kong are comparable to those observed in western
countries. The prevalence of being overweight in this
study is broadly similar to that of SMI patients screened
using the HIP in Scotland; Shuel et al., [20] reported that
77% of patients were overweight (72% were overweight
at follow-up in the present study). Whilst central obesity
was slightly less prevalent in this study (61% compared
to 70% in Scotland), rates of hypertension were higher
(21% verses 13%) and raised plasma glucose levels were
also more common (14% compared to 10% in Scotland).
Interestingly, with the exception of alcohol use and fruit/
vegetable consumption the self-reported health behaviours
of the patients in this study are somewhat worse than
those reported by Shuel et al., [20]; most noteworthy is
the 64% of patients in Hong Kong who at baseline were
not exercising at recommended levels (in comparison with
29% in Scotland).
Our results show that after one year there were some
encouraging improvements in relation to both health be-
haviours and indicators of cardiovascular risk. Although
not statistically significant, most areas of cardiovascular
risk improved over the course of the study. Disappoint-
ingly, despite some slight improvement in BMI, the
mean waist circumference measurement of participants
significantly increased by 2.58 cm at follow-up (p = 0.03).
This result may be confounded by the lack of objective
verification that all the waist circumference measurements
conducted by clinicians adhered to the suggested protocol.
Although the clinicians carrying out measurements were
instructed to place the tape measure across the umbilicus,
Table 4 Mean and SD of cardiovascular risk measurements at baseline and follow-up
Baseline mean (SD) Follow-up mean (SD) P-value (two-tailed)
BMI (n = 137) 25.79 (4.72) 25.66 (4.65) P = 0.55
Weight (n = 129) 66.76 (13.63) 66.49 (12.79) P = 0.67
Waist circumference - cm (n = 90) 87.32 (11.84) 89.90 (12.90) P = 0.03*
Blood pressure - diastolic (n = 96) 81.93 (11.30) 80.77 (10.35) P = 0.40
Blood pressure - systolic (n = 96) 127.09 (16.11) 125.05 (14.93) P = 0.18
Total cholesterol - mmol/L (n = 33) 4.64 (1.20) 4.30 (1.42) P = 0.24
LDL cholesterol - mmol/L (n = 33) 2.49 (0.76) 2.80 (1.36) P = 0.19
Fasting plasma glucose - mmol/L (n = 53) 5.99 (2.31) 5.96 (1.76) P = 0.89
Triglycerides (n = 31) 1.49 (0.75) 1.49 (0.77) P = 0.99
P for significant differences in cardiovascular risk between baseline and follow-up, tested by paired samples T-tests; *Statistically significant at p < 0.05.
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there are at least 6 established alternative waist measure-
ment points that are used routinely in practice, which are
equally predictive of cardiovascular risk but which will all
produce different results [25].
In terms of the health behaviours which are modifiable
physical health risk factors; all areas showed minor
improvements, including a 7% increase in the number
of patients eating sufficient fruit and vegetables, but only ex-
ercise improved to a statistically significant level (p = 0.02).
Therefore, despite some positive outcomes in health
behaviours, with the exception of waist circumference
the physical state of patients remained largely unchanged
over the 12 month period of the study. Our findings are
similar to some of the previous exercise and nutritional
studies which have shown that although health behaviours
improved in patients with SMI, this did not manifest in
significant reductions in BMI, waist circumference or
Table 5 Flagged indicators of cardiovascular risk at baseline
and follow-up
Baseline
n (%)
Follow-up
n (%)
P-value
BMI overweight - Hong Kong
criterion
P = 0.15
Red flagged (BMI≥ 23) 113 (76.4) 106 (71.6)
Green flagged (BMI = 18.50-22.99) 31 (20.9) 40 (27.0)
Missing 4 (2.7) 2 (1.4)
BMI overweight- international
criterion
P = 0.58
Red flagged (BMI≥ 25) 83 (56.1) 79 (53.4)
Green flagged (BMI = 18.50-24.99) 65 (43.9) 68 (45.9)
Missing 0 1 (0.7)
Waist circumference P = 0.07
Red flagged (males ≥ 90 cm,
females≥ 80 cm)
78 (52.7) 90 (60.8)
Green flagged (males < 90 cm,
females < 80 cm)
68 (45.9) 57 (38.5)
Missing 2 (1.4) 1 (0.7)
Hypertension P = 1.00
Red flagged (BP ≥ 140/90) 32 (21.6) 32 (21.6)
Green flagged (BP < 140/90) 115 (77.7) 116 (78.4)
Missing 1 (0.7) 0
Hypercholesterolemia P = 0.38
Red flagged
(Total Cholesterol ≥ 6.2 mmol/L)
36 (24.3) 21 (14.2)
Green flagged (< 6.2 mmol/L) 83 (56.1) 83 (56.1)
Missing 29 (19.6) 44 (29.7)
Raised LDL cholesterol P = 0.21
Red flagged (LDL≥ 4.1 mmol/L) 29 (19.6) 13 (8.8)
Green flagged (< 4.1 mmol/L) 95 (64.2) 93 (62.8)
Missing 24 (16.2) 42 (28.4)
Raised fasting plasma glucose P = 0.21
Red flagged
(Glucose - ≥ 7.00 mmol/L)
16 (10.8) 21 (14.2)
Green flagged (< 7.0 mmol/L) 116 (78.4) 83 (56.1)
Missing 16 (10.8) 44 (29.7)
Raised triglycerides P = 1.00
Red flagged
(Triglycerides - ≥ 2.2 mmol/L)
39 (26.4) 24 (16.2)
Green flagged (< 2.2 mmol/L) 84 (56.8) 75 (50.7)
Missing 25 (16.9) 49 (33.1)
P for significant differences in cardiovascular risk between baseline and follow-up,
tested by McNemar test.
Table 6 Health behaviours of participants at baseline and
follow-up
Health behaviour Baseline
n (%)
Follow-up
n (%)
P-value
Alcohol intake P = 0.79
Red flagged (≥ 4 units daily) 9 (6.1) 7 (4.7)
Green flagged (< 2-3 units/day) 128 (86.5) 141 (95.3)
Unknown 11 (7.4) 0
Smoking status P = 0.45
Red flagged (smoker/passive smoker) 40 (27.0) 36 (24.3)
Green flagged (non-smoker/non
passive smoker)
108 (73.0) 112 (75.7)
Caffeine intake P = 0.79
Red flagged (≥ 600 mg/day) 8 (5.4) 6 (4.1)
Green flagged (< 600 mg/day) 130 (87.8) 142 (95.9)
Unknown 10 (6.8) 0
Exercise P = 0.02*
Red flagged (< 30 minutes a day
for 5 days per week)
95 (64.2) 78 (52.7)
Green flagged (≥ 30 minutes a day
for 5 days per week)
50 (33.8) 69 (46.6)
Unknown 3 (2.0) 1 (0.7)
Diet fruit and vegetables P = 0.08
Red flagged (≤ 2 daily portions) 41 (27.7) 31 (20.9)
Green flagged (≥ 5 daily portions) 106 (71.6) 117 (79.1)
Unknown 1 (0.7)
Diet Fats P = 0.74
Red flagged (≥ 2 portions per day) 30 (20.3) 28 (18.9)
Green flagged (≤ 1 portion per day) 114 (77.0) 120 (81.1)
Unknown 4 (2.7) 0
Disrupted sleep P = 0.15
Red flagged (>8 h or <3 h) 40 (27.0) 51 (34.5)
Green flagged (7 – 8 hours) 107 (72.3) 96 (64.9)
Unknown 1 (0.7) 1 (0.7)
P for significant differences between health behaviours at baseline and follow-up,
tested by McNemar test; * = Statistically significant at p < 0.05.
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body weight, however the interventions may have pre-
vented further deterioration [26-29].
Given the poor physical state of patients at commence-
ment of the study it would be appropriate to assume that
physical health would have deteriorated further after 1 year
and this could indicate that the enhanced screening using
the HIP prevented some further decline. This hypothesis
is supported by the observed marked physical health
deterioration in treatment as usual (TAU) SMI control
groups in some previous studies, for example: Littrell et al.,
[30] report that the mean weight in the TAU group steadily
increased over 16 weeks in a psycho-educational study;
the TAU group in a healthy living programme showed a
8.1% gain in BMI over one year [31] and mean waist cir-
cumference increased by 1.2 cm over three months in the
TAU group in a “solution for wellness” group intervention
programme conducted by Porsdal et al., [32].
Our results highlight that there was little change in the
numbers and types of psychotropic medications prescribed
over the duration of the study. But there was a significant
reduction in the numbers of patients being treated with
medications for diabetes; this is a promising finding and
could suggest that the improvements in exercise and diet
have resulted in better glycaemic control, necessitating a
reduced need for medication. However, due to the lack of
control group, abundance of extraneous variables and in
the absence of objective measures of health behaviour
changes, it is not possible to confidently attribute im-
provements in the need for diabetes treatments to the en-
hanced screening programme. Despite the methodological
shortfalls of the present study, our hypothesis may be
supported by many previous research studies which
show that people with sedentary lifestyles and poor dietary
habits have a substantially increased risk of diabetes [33,34],
and also that exercise and diet interventions can reduce
the risk of diabetes more dramatically than the effects of
medication [35].
The study demonstrates that use of the HIP as a
screening tool in Hong Kong is both feasible and useful to
identify areas where physical health requires intervention.
As a potential secondary gain enhanced physical health
monitoring may also address concerns about treatment;
Bressington et al., [36] demonstrated that patients and
families in Hong Kong are concerned about the effects of
psychotropic medications on patients’ physical health, if
there is increased attention in this area perhaps this will
go some way to reinforcing that these concerns are being
taken seriously and hence provide some reassurance in
this regard. The numbers of patients who agreed to
participate and completed the study suggest that an in-
creased clinical focus on physical health problems is
acceptable from a patient perspective, but in order to
maximise the potential of health behaviour interventions
clinicians need to ensure that there are adequate services
available to provide ongoing support; which will entail a
co-ordinated interprofessional intensive effort from health
care workers.
Strengths and limitations of the study
We are unable to make assertions from our results about
causality due to the prospective case series design of the
study. Due to the lack of a control group and absence of
objective measures of behaviour it is not possible to
confidently ascribe the improvements in health behav-
iours or lack of deterioration in physical health to the
HIP screening programme; the changes in physical state
may result from natural fluctuations, response to prescribed
medical treatments or other influences. Patients’ self–re-
ported their health behaviours, and therefore potentially an
overly positive picture may have been presented in an effort
to please their keyworkers. The recruitment process may
also have introduced selection bias and the sparseness of
data relating to blood tests may have resulted in lack of
power and therefore statistical significance may be affected.
Despite the methodological limitations of this study,
the results demonstrate that enhanced physical health
screening using the HIP is feasible and acceptable in this
setting; if at the very least such screening programmes
prevent deterioration in physical health then this would
be a clinically meaningful outcome. In terms of future
research, this study shows that it is possible to recruit
and retain patients with SMI in health screening studies,
and as clinicians were able to use the HIP to integrate
relatively inexpensive health screening into routine clinical
practice it would be sensible conduct further studies which
utilise a randomised controlled trial design and employ a
randomised recruitment strategy.
Conclusions
Annual health checks using the HIP are useful in monitor-
ing the physical health of patients with SMI and are also
effective in identifying individualised targets for clinical
intervention. The results show that over the 12-month
duration of the study the amounts of self-reported exer-
cise improved and the numbers of patients prescribed
diabetes medications reduced, but mean waist circumfer-
ence increased. In this instance the enhanced screening
programme does not seem to have significantly improved
patients’ cardiovascular risk factors, but may have resulted
in the prevention of further health deterioration.
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